Physician
Vernovsky, Natalya
Vernovsky, Natalya was paid $39K by Medicaid between May 2022 and Dec 2023, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoVERNOVSKY, NATALYA
MORTON GROVE, IL 60053
MORTON GROVE, IL 60053
33aNPI1730194192assigned 07/31/2006
33bProvider typePediatrics Physician
28Total paid$39K
24GClaims681
24DCodes billed7
24AFirst – last monthMay 2022 – Dec 2023
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#991 of 1,805
Median peer was paid$55K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 414 | $25K | |
| 2023 | 267 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 453 | 442 | $21K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 29% | 81 | 76 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.0% | 60 | 59 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.6% | 35 | 31 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 13 | 13 | $628.18 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 20 | 14 | $290.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 19 | 14 | $2.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.